Ballicules.com

Miconazole

MONISTAT

Pronunciation: mi-KON-a-zoel

Miconazole ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Miconazole ballicule

What it isImidazole CYP51 inhibitor; cutaneous, vulvovaginal, and oropharyngeal fungal infections.

Why this oneIts topical, vaginal, and buccal formulations treat local disease with little systemic exposure.

What limits it⚑ Even vaginal or buccal use can potentiate warfarin enough to cause bleeding; local irritation is common.

Miconazole molecular structure (skeletal formula)
Molecular structure: Miconazole

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Vaginal yeast infection≥12 yr1 applicatorful intravaginally QHS ×7 nights
External vulvar itching/irritation≥12 yrapply to vulva BID ×up to 7 days PRN

Renal Undefined

Hepatic Undefined

Instructions

Available strengths

Pregnancy Undefined

Lactation Undefined

Cost

Miconazole (MONISTAT)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/unitCostPlus
2 %creamper unitnot offered
4 %creamper unitnot offered
100 mgsuppper unitnot offered
200 mgsuppper unit$13.89/eaoffered

Generic entry1992

NO BOXED WARNINGS

Principal riskEven topical forms raise warfarin enough to cause bleeding

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryC

Defining liabilityLocal irritation or hypersensitivity; systemic toxicity is minimal with correct local use.

Open Miconazole in the interactive console ↗